5AM Ventures
Overview
5AM Ventures is a life science-focused investment firm that funds and builds next-generation therapeutic and life science companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mendra, Inc. | Jan 2026 | Series A | Lead |
| Mendra, Inc. | Jan 2026 | Series A | Lead |
| Precede Biosciences | Jan 2026 | Series B | Co-investor |
| Kinaset Therapeutics | Jan 2026 | Series B | Co-investor |
| ProLynx Inc. | Dec 2025 | Series A | Lead |
Key People
Scott Rocklage
Founding Partner
Andy Schwab
Managing Partner
John Diekman
Founding and Managing Partner
Kush Parmar
Managing Partner
Arthur Tzianabos
Venture Partner
Elliott Levy
Venture Partner
Joshua Grass
Venture, Venture Partner
Paula Soteropoulos
Venture Partner
Steve Hitchcock
Venture Partner
Anna Cosslett Yaeger
Partner, Head Of Public Equities
Michael Calore
Partner, Head Of Investor Relations
Stone Paul A.
Partner, Chief Legal Officer, Chief Compliance Officer
John Kelly
Partner, Chief Financial Officer, Chief Operating Officer
Katie Bodner Spielberg
Principal
Max Farina
Principal
Britt Inga Emerson
Investor Relations Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.